Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 October, 2018 20:33 IST
Zydus Cadila receives USFDA tentative approval for 2 drugs
Source: IRIS | 12 Oct, 2018, 01.12PM
Comments  |  Post Comment

Zydus Cadila has received the tentative approval from the USFDA to market Linagliptin and Metformin HydrochlorideTablets, 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/ 1,000 mg.



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Lupin's Pithampur unit-3 inspected by USFDA - 19-Oct-2018 16:01
Surya Roshni bags order worth Rs 503.4 mn - 19-Oct-2018 11:22
Glenmark Pharma to present data on investigational treatment for Atopic Dermatitis - 19-Oct-2018 09:55
Roadmap to promote aircraft manufacturing on anvil: Suresh Prabhu - 19-Oct-2018 09:36
Zydus Cadila receives tentative approval for Colchicine tablets - 18-Oct-2018 16:21
Ramco Systems partners with Airbus Helicopters SAS - 18-Oct-2018 10:26
ABB secures order worth Rs 1.15 bn from Indian Railways - 18-Oct-2018 10:20
Zydus Cadila gets nod for Clobetasol propionate cream - 17-Oct-2018 15:19
Aurionpro Solutions to acquire majority stake in Singapore based SC Soft - 17-Oct-2018 13:26
L&T Technology Services completes acquisition of Graphene Semiconductor Services - 17-Oct-2018 13:22
Adani Group partners with Total to provide multi-energy offering - 17-Oct-2018 13:16
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer